USA v. APRAHAMIAN
Case Number:
2:20-cr-00064
Court:
Nature of Suit:
Judge:
Firms
-
December 15, 2023
DOJ Slams Teva's Bid For Answers On Dropped Case
Federal prosecutors urged a Pennsylvania federal judge on Friday to reject Teva Pharmaceuticals' attempt to unseal a letter explaining the government's decision to drop generic drug price-fixing charges against a New York pharmaceutical marketing executive, saying the letter isn't subject to the First Amendment's right of access.
-
November 17, 2023
Feds Drop Price-Fixing Case Against Former Drug Exec
A New York pharmaceutical marketing executive will have his Pennsylvania federal court case dropped after prosecutors on Thursday asked to dismiss the three charges alleging he participated in a scheme to fix prices of generic drugs.
-
March 28, 2023
DOJ Fights Pharma Exec's Bid To Delay Price-Fixing Trial
The U.S. Department of Justice has pushed back against a bid by a former pharmaceutical executive accused of taking part in conspiracies to fix generic drug prices to delay a pending October trial, arguing that the case has already been pending for three years.
-
November 09, 2022
Drug Buyers, States Want To Depose Indicted Ex-Taro Exec
A group of drug purchasers and state-level enforcers accusing generic-drug manufacturers of fixing prices asked a Pennsylvania federal court on Tuesday to allow it to depose a former top executive who was indicted on criminal antitrust charges ahead of his trial.
-
January 03, 2021
Antitrust Conduct Cases To Watch In 2021
U.S. technology companies are facing a mountain of antitrust litigation heading into 2021, as enforcers push blockbuster monopolization cases against Google and Facebook. Meanwhile, long-running criminal probes in the generic drug and poultry industries are heating up. Here’s a look at the biggest antitrust conduct cases to watch.
-
June 18, 2020
DOJ Wants To Keep Generic-Drug Exec's Case In Pa.
Even though a former top pharmaceutical executive at Taro Pharmaceutical Industries Ltd. is accused of lying to an FBI agent in New York about his participation in a price-fixing scheme, prosecutors say they want him to be tried in Pennsylvania.
-
May 20, 2020
Indicted Generic-Drug Exec Wants Case Tried In New York
A former top pharmaceutical executive facing price-fixing charges from the U.S. Department of Justice has requested that the case be moved from Pennsylvania to New York federal court.
-
February 04, 2020
3rd Generic Drug Executive Indicted For Price-Fixing
The U.S. Department of Justice accused a former top executive at Taro Pharmaceutical Industries Ltd. of plotting to fix prices of antibiotics and diabetes treatments in Pennsylvania federal court on Tuesday — the third executive charged in the watchdog's criminal probe of the generic drug industry.